Cargando…

Health economic design for cost, cost-effectiveness and simulation analyses in the HEALing Communities Study

BACKGROUND: The HEALing Communities Study (HCS) is designed to implement and evaluate the Communities That HEAL (CTH) intervention, a conceptually driven framework to assist communities in selecting and adopting evidence-based practices to reduce opioid overdose deaths. The goal of the HCS is to pro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aldridge, Arnie P., Barbosa, Carolina, Barocas, Joshua A., Bush, Joshua L., Chhatwal, Jagpreet, Harlow, Kristin J., Hyder, Ayaz, Linas, Benjamin P., McCollister, Kathryn E., Morgan, Jake R., Murphy, Sean M., Savitzky, Caroline, Schackman, Bruce R., Seiber, Eric E., E Starbird, Laura, Villani, Jennifer, Zarkin, Gary A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier B.V. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7532345/ https://www.ncbi.nlm.nih.gov/pubmed/33152672 http://dx.doi.org/10.1016/j.drugalcdep.2020.108336

Ejemplares similares

Cost-Effectiveness of Remdesivir for COVID-19 Treatment: What Are We Missing?
por: Chhatwal, Jagpreet, et al.
Publicado: (2022)

Clinical impact, costs, and cost-effectiveness of hospital-based strategies for addressing the US opioid epidemic: a modelling study
por: Barocas, Joshua A, et al.
Publicado: (2022)

Cost analysis in implementation studies of evidence-based practices for mental health and substance use disorders: a systematic review
por: Bowser, Diana M., et al.
Publicado: (2021)

Cost Effectiveness and Cost Containment in the Era of Interferon-Free Therapies to Treat Hepatitis C Virus Genotype 1
por: Linas, Benjamin P., et al.
Publicado: (2016)

Implementation and first-year operating costs of an academic medical center-based syringe services program
por: Bartholomew, Tyler S., et al.
Publicado: (2021)

Harmonizing healthcare and other resource measures for evaluating economic costs in substance use disorder research
por: Papp, Michelle A., et al.
Publicado: (2021)

A new methodology for examining the efficacy of SBIRT protocols on reducing healthcare utilization and costs
por: Pringle, Janice, et al.
Publicado: (2015)

Comparison of Rates of Overdose and Hospitalization After Initiation of Medication for Opioid Use Disorder in the Inpatient vs Outpatient Setting
por: Morgan, Jake R., et al.
Publicado: (2020)

Assessment of the Feasibility and Cost of Hepatitis C Elimination in Pakistan
por: Chhatwal, Jagpreet, et al.
Publicado: (2019)

A clash of epidemics: Impact of the COVID-19 pandemic response on opioid overdose
por: Linas, Benjamin P., et al.
Publicado: (2021)

Association of Limited In-Person Attendance in US National Football League and National Collegiate Athletic Association Games With County-Level COVID-19 Cases
por: Toumi, Asmae, et al.
Publicado: (2021)

Cost-effectiveness Analysis of Bariatric Surgery for Patients With Nonalcoholic Steatohepatitis Cirrhosis
por: Klebanoff, Matthew J., et al.
Publicado: (2019)

Cost‐effectiveness of aducanumab to prevent Alzheimer's disease progression at current list price
por: Sinha, Pranay, et al.
Publicado: (2022)

Estimating the price at which hepatitis C treatment with direct-acting antivirals would be cost-saving in Japan
por: Zhuo, Yueran, et al.
Publicado: (2020)

Estimated Reductions in Opioid Overdose Deaths With Sustainment of Public Health Interventions in 4 US States
por: Chhatwal, Jagpreet, et al.
Publicado: (2023)

Estimated Clinical Outcomes and Cost-effectiveness Associated With Provision of Addiction Treatment in US Primary Care Clinics
por: Jawa, Raagini, et al.
Publicado: (2023)

58. Cost-Effectiveness of Emerging Antibiotic Strategies for the Treatment of Drug-Use Associated Infective Endocarditis
por: Adams, Joella W, et al.
Publicado: (2021)

Rural and urban differences in undersupply of buprenorphine provider availability in the United States, 2018
por: Conway, Kevin P., et al.
Publicado: (2022)

Cost-effectiveness of hepatitis C treatment using generic direct-acting antivirals available in India
por: Aggarwal, Rakesh, et al.
Publicado: (2017)

Assessing cost-effectiveness of hepatitis C testing pathways in Georgia using the Hep C Testing Calculator
por: Adee, Madeline, et al.
Publicado: (2021)

Cost-effectiveness of Screening for Atrial Fibrillation Using Wearable Devices
por: Chen, Wanyi, et al.
Publicado: (2022)

Author Correction: Assessing cost-effectiveness of hepatitis C testing pathways in Georgia using the Hep C Testing Calculator
por: Adee, Madeline, et al.
Publicado: (2022)

Program- and service-level costs of seven screening, brief intervention, and referral to treatment programs
por: Bray, Jeremy W, et al.
Publicado: (2014)

Simulated Cost-effectiveness and Long-term Clinical Outcomes of Addiction Care and Antibiotic Therapy Strategies for Patients With Injection Drug Use–Associated Infective Endocarditis
por: Adams, Joëlla W., et al.
Publicado: (2022)

Implementation costs of screening and brief intervention for illicit drug use
por: Zarkin, Gary, et al.
Publicado: (2013)

An Overlapping Systems Conceptual Framework to Evaluate Implementation of a Behavioral Health Intervention for Justice–Involved Youth
por: Bowser, Diana, et al.
Publicado: (2019)

Projecting COVID-19 Mortality as States Relax Nonpharmacologic Interventions
por: Linas, Benjamin P., et al.
Publicado: (2022)

Improved Health Outcomes from Hepatitis C Treatment Scale-Up in Spain’s Prisons: A Cost-Effectiveness Study
por: Dalgic, Ozden O., et al.
Publicado: (2019)

Cost-Effectiveness of Testing and Treatment for Hepatitis B Virus and Hepatitis C Virus Infections: An Analysis by Scenarios, Regions, and Income
por: Tordrup, David, et al.
Publicado: (2020)

Boceprevir for previously untreated patients with chronic hepatitis C Genotype 1 infection: a US-based cost-effectiveness modeling study
por: Ferrante, Shannon Allen, et al.
Publicado: (2013)

Acceptability of Rapid Point-of-Care Hepatitis C Tests Among People Who Inject Drugs and Utilize Syringe-Exchange Programs
por: Barocas, Joshua A., et al.
Publicado: (2016)

The cost of antiretroviral therapy in Haiti
por: Koenig, Serena P, et al.
Publicado: (2008)

Economic Evaluation of Extended-Release Buprenorphine for Persons With Opioid Use Disorder
por: Flam-Ross, Juliet M., et al.
Publicado: (2023)

Health Economics of Interventions to Tackle the Coronavirus 2019 Pandemic
por: Chhatwal, Jagpreet, et al.
Publicado: (2021)

COVID-19 Health Economics: Looking Back and Scoping the Future
por: Postma, Maarten J., et al.
Publicado: (2022)

Comparing Projected Fatal Overdose Outcomes and Costs of Strategies to Expand Community-Based Distribution of Naloxone in Rhode Island
por: Zang, Xiao, et al.
Publicado: (2022)

Two Polar Considerations in Treatment System Planning: Infrastructure Development and Real-Time Management
por: Aldridge, Arnie
Publicado: (2019)

What Is the Optimal Threshold at Which to Recommend Breast Biopsy?
por: Burnside, Elizabeth S., et al.
Publicado: (2012)

Stability of Drinking Reductions and Long-term Functioning Among Patients with Alcohol Use Disorder
por: Witkiewitz, Katie, et al.
Publicado: (2020)

Optimal use of the AUDIT in screening and brief intervention programs: a decision theoretic approach (part of Economics of SBI symposium)
por: Aldridge, Arnie, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_deaivpai3g8r9gpv2t3o5rflvo